Two first-in-class molecules from EyeBio have shown promising results for the treatment of retinal diseases, according to a presenter at [email protected] (MK-3000) is an antibody that ...
Parabilis Medicines, a clinical-stage biopharmaceutical company committed to creating extraordinary medicines for people ...
Researchers uncover how cells develop and specialize, advancing prospects for regenerative dental treatments. Researchers at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback